Publications

Interactions between timing and transmissibility explain diverse flavivirus dynamics in Fiji

Henderson AD. et al, (2021), Nature Communications, 12

Chemoprophylaxis trial designs in epidemics: insights from a systematic review of COVID-19 study registrations.

Manoharan L. et al, (2021), Trials, 22

Electronic data management for vaccine trials in low resource settings: Upgrades, scalability and impact of ODK

Marks M. et al, (2021)

Influenza in carehome residents: applying a conceptual framework to describe barriers to the implementation of guidance on treatment and prophylaxis

Phipps E. et al, (2020), Journal of Public Health, 42, 602 - 609

Zika seroprevalence declines and neutralizing antibodies wane in adults following outbreaks in French Polynesia and Fiji.

Henderson AD. et al, (2020), eLife, 9

Low chikungunya virus seroprevalence two years after emergence in Fiji.

Aubry M. et al, (2020), International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 90, 223 - 225

The Invisible Burden: Diagnosing and Combatting Typhoid Fever in Asia and Africa.

Pitzer VE. et al, (2019), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 69, S395 - S401

Sustained Low-Level Transmission of Zika and Chikungunya Viruses after Emergence in the Fiji Islands.

Kama M. et al, (2019), Emerging infectious diseases, 25, 1535 - 1538

Design of vaccine efficacy trials during public health emergencies

Dean NE. et al, (2019), Science Translational Medicine, 11, eaat0360 - eaat0360

Determinants of Transmission Risk During the Late Stage of the West African Ebola Epidemic

Robert A. et al, (2019), American Journal of Epidemiology, 188, 1319 - 1327

Ross River Virus Antibody Prevalence, Fiji Islands, 2013–2015

Aubry M. et al, (2019), Emerging Infectious Diseases, 25, 827 - 830

Zika virus seroprevalence declines and neutralization antibodies wane in adults following outbreaks in French Polynesia and Fiji

Henderson AD. et al, (2019)

Predictive risk mapping of an environmentally-driven infectious disease using spatial Bayesian networks: A case study of leptospirosis in Fiji

Mayfield HJ. et al, (2018), PLOS Neglected Tropical Diseases, 12, e0006857 - e0006857

Using paired serology and surveillance data to quantify dengue transmission and control during a large outbreak in Fiji

Kucharski AJ. et al, (2018), eLife, 7

Use of geographically weighted logistic regression to quantify spatial variation in the environmental and sociodemographic drivers of leptospirosis in Fiji: a modelling study

Mayfield HJ. et al, (2018), The Lancet Planetary Health, 2, e223 - e232

Considerations for the design of vaccine efficacy trials during public health emergencies

Dean NE. et al, (2018)

Role of Environmental Factors in Shaping Spatial Distribution ofSalmonella entericaSerovar Typhi, Fiji

de Alwis R. et al, (2018), Emerging Infectious Diseases, 24, 284 - 293

Social mixing in Fiji: Who-eats-with-whom contact patterns and the implications of age and ethnic heterogeneity for disease dynamics in the Pacific Islands

Watson CH. et al, (2017), PLOS ONE, 12, e0186911 - e0186911

Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety report.

Gsell P-S. et al, (2017), The Lancet. Infectious diseases, 17, 1276 - 1284

Unravelling infectious disease eco-epidemiology using Bayesian networks and scenario analysis: A case study of leptospirosis in Fiji

Lau CL. et al, (2017), Environmental Modelling & Software, 97, 271 - 286